These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Decreased expression of vesicular GABA transporter, but not vesicular glutamate, acetylcholine and monoamine transporters in rat brain following focal ischemia. Vemuganti R Neurochem Int; 2005 Jul; 47(1-2):136-42. PubMed ID: 15936116 [TBL] [Abstract][Full Text] [Related]
5. Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry. Schenk JO; Wright C; Bjorklund N J Neurosci Methods; 2005 Apr; 143(1):41-7. PubMed ID: 15763135 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters. Vaughan RA J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332 [TBL] [Abstract][Full Text] [Related]
8. Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells. Chen CX; Huang SY; Zhang L; Liu YJ Neurobiol Dis; 2005 Aug; 19(3):419-26. PubMed ID: 16023584 [TBL] [Abstract][Full Text] [Related]
9. Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity. Jørgensen S; Nielsen EØ; Peters D; Dyhring T J Neurosci Methods; 2008 Mar; 169(1):168-76. PubMed ID: 18222006 [TBL] [Abstract][Full Text] [Related]
10. Brain iron homeostasis and neurodegenerative disease. Benarroch EE Neurology; 2009 Apr; 72(16):1436-40. PubMed ID: 19380704 [No Abstract] [Full Text] [Related]
11. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner. Zhang S; Zhen J; Reith ME; Dutta AK J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of 5-HT6 receptor ligands. Mancinelli A Int Rev Neurobiol; 2010; 94():153-72. PubMed ID: 21081206 [No Abstract] [Full Text] [Related]
13. SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism. Lin Z; Walther D; Yu XY; Li S; Drgon T; Uhl GR Hum Mol Genet; 2005 May; 14(10):1393-404. PubMed ID: 15829504 [TBL] [Abstract][Full Text] [Related]
14. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541 [TBL] [Abstract][Full Text] [Related]
16. Monoamine transporters in human endometrium and decidua. Hansson SR; Bottalico B; Noskova V; Casslén B Hum Reprod Update; 2009; 15(2):249-60. PubMed ID: 18987100 [TBL] [Abstract][Full Text] [Related]
17. The unilateral nigral lesion induces dramatic bilateral modification on rat brain monoamine neurochemistry. Pierucci M; Di Matteo V; Benigno A; Crescimanno G; Esposito E; Di Giovanni G Ann N Y Acad Sci; 2009 Feb; 1155():316-23. PubMed ID: 19250223 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous real-time amperometric measurement of catecholamines and serotonin at carbon fibre 'dident' microelectrodes. Pennington JM; Millar J; L Jones CP; Owesson CA; McLaughlin DP; Stamford JA J Neurosci Methods; 2004 Dec; 140(1-2):5-13. PubMed ID: 15589328 [TBL] [Abstract][Full Text] [Related]
19. Use of proteomics for the identification of novel drug targets in brain diseases. Morón JA; Devi LA J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802 [TBL] [Abstract][Full Text] [Related]